Grantham, Mayo, Van Otterloo & Co (GMO)
PAHC icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Phibro Animal Health PAHC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,250
Closed -$309K – 763
2022
Q3 		$309K Sell
23,250
-14,550
-38% -$251K ﹤0.01% 626
2022
Q2 		$723K Hold
37,800
– – ﹤0.01% 562
2022
Q1 		$754K Buy
37,800
+5,000
+15% +$101K ﹤0.01% 556
2021
Q4 		$670K Buy
+32,800
New +$700K ﹤0.01% 574
2021
Q1 		– Sell
-20,600
Closed -$400K – 913
2020
Q4 		$400K Sell
20,600
-43,800
-68% -$806K ﹤0.01% 715
2020
Q3 		$1.12M Buy
64,400
+12,900
+25% +$275K 0.01% 499
2020
Q2 		$1.35M Buy
+51,500
New +$1.28M 0.01% 485
2019
Q2 		– Sell
-11,900
Closed -$393K – 759
2019
Q1 		$393K Sell
11,900
-4,100
-26% -$128K ﹤0.01% 612
2018
Q4 		$515K Hold
16,000
– – ﹤0.01% 435
2018
Q3 		$686K Hold
16,000
– – ﹤0.01% 418
2018
Q2 		$737K Buy
+16,000
New +$708K 0.01% 413

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PAHC Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 23,250 shares — an estimated $309K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PAHC in Q2 2018 and held it in 11 quarters. The position peaked at $1.35M in Q2 2020. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 23,250 Phibro Animal Health shares in Q4 2022, an estimated $309K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Phibro Animal Health in Q2 2018 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Phibro Animal Health position peaked at $1.35M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.